ArticleHemaSphere2026

Validation of the new IMS/IMWG consensus genomic staging (CGS) of high-risk multiple myeloma (HRMM) in a contemporary cohort of 1209 patients.

Efstathios Kastritis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.